Notify me when WESTFIELD CAPITAL MANAGEMENT CO LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | Common Stock | 8.5% | $1,115,183,925 | -$73,663,872 | 5,185,696 | -6.2% | Westfield Capital Management Company, L.P. | 31 Dec 2025 |
| INVA | Innoviva, Inc. | Common Stock | 0% | $0 | 0 | Westfield Capital Management Company, L.P. | 31 Dec 2024 | ||
| FLYW | Flywire Corp | Common Stock | 0% | $0 | -$57,471,508 | 0 | -100% | Westfield Capital Management Company, L.P. | 28 Feb 2025 |
| BCYC | BICYCLE THERAPEUTICS PLC | Common Stock | 0% | $0 | 0 | Westfield Capital Management Company, L.P. | 28 Feb 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|